Drug Profile
Cytokine-induced killer cell therapy - Alliancells-PuRui Biosciences
Alternative Names: CIK cells; Cord CIK cellsLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Alliancells-PuRui Bioscience
- Developer Alliancells-PuRui Bioscience; Zhongyuan Union Stem Cell Bio-engineering Corporation
- Class Cell therapies; Gene therapies
- Mechanism of Action Cytokine-induced killer cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for phase-I development in Solid-tumours in China (IV-infusion)
- 01 Mar 2015 Phase-I clinical trials in Solid tumours in China (IV-infusion) (NCT01914263)
- 29 Jul 2013 Preclinical trials in Solid tumours in China (IV-infusion)